Drug Profile
Research programme: progesterone intranasal - BHR Pharma
Alternative Names: BHR-310Latest Information Update: 25 Dec 2021
Price :
$50
*
At a glance
- Originator BHR Pharma
- Class Hormonal contraceptives; Hormonal replacements; Infertility therapies; Pregnenediones; Small molecules
- Mechanism of Action Apoptosis inhibitors; GABA modulators; Glutamate antagonists; Interleukin 1 beta inhibitors; Interleukin 6 inhibitors; Lipid peroxidation inhibitors; Tumour necrosis factor alpha inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Brain injuries
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Brain injuries in USA (Intranasal, Spray)
- 24 Jul 2012 Preclinical trials in Brain injuries in USA (Intranasal)